Company
Headquarters: Double Bay, NSW, Australia
A$28.6 Million
AUD as of Oct. 1, 2021
US$20.8 Million
Company | Market Cap (USD) |
---|---|
Procter & Gamble | $350.35 B |
L'Oréal | $262.20 B |
Unilever | $121.89 B |
Colgate-Palmolive Company | $66.15 B |
Reckitt Benckiser Group plc | $50.09 B |
Company | Market Cap (USD) |
---|---|
Walmart | $428.87 B |
Procter & Gamble | $350.35 B |
Kweichow Moutai | $299.54 B |
Costco | $287.69 B |
L'Oréal | $262.20 B |
Bod Australia Limited operates as a cannabis centric healthcare company in Australia, the United Kingdom, and internationally. The company operates through three segments: Medical, OTC CBD/Hemp, and OTC Herbals. It offers medicinal cannabis, cannabidiol (CBD), and hemp healthcare products. The company has a collaboration agreement with Drug Science UK to assess the efficacy of its medicinal cannabis, MediCabilis in managing symptoms associated with the long term impact of SARS-CoV-2. Bod Australia Limited was incorporated in 2014 and is based in Double Bay, Australia.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Bod Australia Limited has the following listings and related stock indices.
Stock: ASX: BDA wb_incandescent
Stock: ASX: BOD wb_incandescent